Literature DB >> 6757925

Inhibition of cell growth by a hypothalamic peptide.

T W Redding, A V Schally.   

Abstract

A fraction purified from acetic acid extracts of porcine hypothalami was found to contain significant antimitogenic activity when tested in normal and neoplastic cell lines. Addition of this hypothalamic material (1-100 micrograms/ml) to culture media significantly inhibited [3H]thymidine incorporation into cellular DNA in several cell lines. Amino acid incorporation into pituitary proteins and uridine incorporation into RNA were also significantly reduced by this factor(s). Addition to the culture media of this hypothalamic material at 5 micrograms/ml and 50 micrograms/ml per day decreased by 17% and 36%, respectively, cell numbers of 3T6 fibroblast cell cultures. Time-response curves showed that the inhibition of [3H]thymidine incorporation into DNA in 3T6 fibroblast cells begins within 2 hr after adding this fraction to the culture medium. The inhibitory action cannot be explained by a direct cytotoxic effect since 3T6 cells labeled with 51Cr and incubated for 6 hr in the presence of this hypothalamic fraction fail to show an increase in the release of 51Cr into the medium as compared with controls. Incubation with trypsin and chymotrypsin completely abolished the antimitogenic activity of this material and pepsin decreased it. This strongly suggests that the antimitogenic activity exhibited by this fraction is due to a polypeptide(s). These observations provide evidence for the presence in the mammalian hypothalamus of an antimitogenic peptide(s) that may be involved in the regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757925      PMCID: PMC347265          DOI: 10.1073/pnas.79.22.7014

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Purification of a fibroblast growth factor from bovine pituitary.

Authors:  D Gospodarowicz
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  Isolation and structure of somatostatin from porcine hypothalami.

Authors:  A V Schally; A Dupont; A Arimura; T W Redding; N Nishi; G L Linthicum; D H Schlesinger
Journal:  Biochemistry       Date:  1976-02-10       Impact factor: 3.162

4.  Nature of rat liver cell sap factors inhibiting the DNA synthesis in tumour cells.

Authors:  M Miyamoto; H Terayama
Journal:  Biochim Biophys Acta       Date:  1971-01-28

5.  Evidence that a rat liver "inhibitor" of the synthesis of DNA in cultured mammalian cells is arginase.

Authors:  R W Holley
Journal:  Biochim Biophys Acta       Date:  1967-09-26

6.  Effect of hypothalamic extracts on protein synthesis in rat anterior pituitary tissue.

Authors:  C K Grieshaber; W C Hymer
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

7.  Polypeptides that inhibit human breast cancer cell division.

Authors:  P T Beall; B Szopa; S R Burzynski; C F Hazlewood
Journal:  Cancer Biochem Biophys       Date:  1979

Review 8.  Growth factors in mammalian cell culture.

Authors:  D Gospodarowicz; J S Moran
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

9.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  3 in total

1.  Therapeutic response to somatostatin analogue, BIM 23014, in metastatic prostatic cancer.

Authors:  H Parmar; C D Charlton; R H Phillips; L Edwards; J L Bejot; F Thomas; S L Lightman
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

2.  Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

Authors:  A V Schally; T W Redding
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 3.  Recent progress in targeting cancer.

Authors:  Zoya N Demidenko; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-12       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.